To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene TRIP13TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
206 supporting clones for gene TRIP13 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BG719501 testis .a 1 to 615 1 to 619   tiling clone,   615/624
(98 %)
7 diff
(98.9 %id)
BG037191 testis .a 25 to 480 1 to 462   tiling clone, fully sequenced,   462/462
(100 %)
3 diff
(99.4 %id)
NM_004237.3   .a 213 to 2602 1 to 2390   RefSeq, AAA   2390/2390
(100 %)
0 diff
(100 %id)
DB443523 testis .a 214 to 430 1 to 217       217/217
(100 %)
8 diff
(96.4 %id)
DB444051 testis .a 214 to 611 1 to 395       395/442
(89 %)
24 diff
(94.6 %id)
BG722761 testis .a 218 to 821 1 to 611       607/611
(99 %)
7 diff
(98.9 %id)
DB451658 testis .a 219 to 714 1 to 496       496/497
(99 %)
4 diff
(99.2 %id)
BG771433 testis .a 229 to 936 1 to 713       713/714
(99 %)
6 diff
(99.2 %id)
DB453204 testis .a 236 to 729 1 to 494       494/494
(100 %)
1 diff
(99.8 %id)
BE264974 lung, small cell carcinoma .a 239 to 890 1 to 657       657/706
(93 %)
11 diff
(98.5 %id)
DB443976 testis .a 243 to 705 1 to 463       463/463
(100 %)
1 diff
(99.8 %id)
DB455631 testis .a 243 to 724 1 to 482       482/482
(100 %)
0 diff
(100 %id)
AW245788 lung, small cell carcinoma .a 244 to 862 6 to 624       619/624
(99 %)
7 diff
(98.9 %id)
DB065970 testis .a 244 to 787 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
BE793233 lung, small cell carcinoma .a 247 to 968 1 to 736       732/1089
(67 %)
32 diff
(97.1 %id)
BC000404 Lung, small cell carcinoma .a 248 to 2596 1 to 2349   tiling clone, available from MGC, AAA   2349/2349
(100 %)
0 diff
(100 %id)
BC019294 Lung, small cell carcinoma .a 248 to 2596 1 to 2349   available from MGC, AAA   2349/2349
(100 %)
0 diff
(100 %id)
BG037082 testis .a 254 to 1016 1 to 773       773/1096
(70 %)
27 diff
(97.6 %id)
DB453497 testis .a 255 to 750 1 to 496       496/496
(100 %)
0 diff
(100 %id)
BP352250   .a 255 to 835 1 to 581       581/581
(100 %)
7 diff
(98.8 %id)
BG721199 testis .a 257 to 791 1 to 560       554/730
(75 %)
45 diff
(93.9 %id)
CN309337 embryonic stem cells, cell lines H1, H7, andH9 .a 258 to 869 1 to 612       612/612
(100 %)
1 diff
(99.9 %id)
BE313711 brain, neuroblastoma .a 264 to 801 1 to 538       538/540
(99 %)
1 diff
(99.9 %id)
BE262619 brain, neuroblastoma .a 266 to 887 34 to 659       622/847
(73 %)
22 diff
(97.5 %id)
BF219780 lung, small cell carcinoma .a 267 to 873 1 to 607       607/607
(100 %)
5 diff
(99.2 %id)
BQ065552 lymph, lymphoma, cell line .a 268 to 1186 1 to 930       930/1019
(91 %)
27 diff
(97.4 %id)
BF206187 brain, neuroblastoma .a 277 to 976 1 to 704       704/812
(86 %)
17 diff
(98.0 %id)
BF316141 brain, neuroblastoma .a 277 to 965 1 to 685       685/928
(73 %)
19 diff
(98.0 %id)
BF314646 brain, neuroblastoma .a 277 to 1031 1 to 744       744/949
(78 %)
12 diff
(98.8 %id)
BP249566 Kidney .a 279 to 859 1 to 583       583/583
(100 %)
7 diff
(98.8 %id)
DB444650 testis .a 282 to 712 1 to 429       429/429
(100 %)
10 diff
(97.7 %id)
BU151375 brain, neuroblastoma, cell line .a 287 to 1188 1 to 902       902/902
(100 %)
7 diff
(99.3 %id)
CN309338 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 298 to 1003 1 to 706       706/706
(100 %)
0 diff
(100 %id)
BE336907 adenocarcinoma cell line, ovary .a 298 to 867 1 to 570       570/570
(100 %)
0 diff
(100 %id)
BQ668848 epidermoid carcinoma, cell line, salivary gland .a 307 to 1121 1 to 819       819/927
(88 %)
11 diff
(98.9 %id)
U96131   .a 313 to 2510 1 to 2200       2200/2203
(99 %)
3 diff
(99.9 %id)
AI358369 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 314 to 759 1 to 446     Submitted on the opposite strand 446/446
(100 %)
1 diff
(99.8 %id)
AI813492 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 315 to 867 1 to 553     Submitted on the opposite strand 553/553
(100 %)
2 diff
(99.7 %id)
TI_154077754   .a 315 to 893 64 to 646     Submitted on the opposite strand 579/656
(88 %)
21 diff
(96.8 %id)
AA972912 pooled .a 316 to 723 1 to 412     Submitted on the opposite strand 408/412
(99 %)
10 diff
(97.6 %id)
AW292892   .a 316 to 865 1 to 546     Submitted on the opposite strand 546/546
(100 %)
4 diff
(99.3 %id)
CN309339 embryonic stem cells, DMSO-treated H9 cellline .a 350 to 871 1 to 522       522/522
(100 %)
0 diff
(100 %id)
TI_1948093646   .a 357 to 996 131 to 770   fully sequenced,   636/766
(83 %)
6 diff
(99.3 %id)
TI_1948093805   .a 357 to 1060 130 to 833   fully sequenced,   700/829
(84 %)
6 diff
(99.3 %id)
TI_1948093975   .a 357 to 1060 138 to 841   fully sequenced,   700/837
(83 %)
9 diff
(99.0 %id)
TI_1948094143   .a 357 to 1060 123 to 826   fully sequenced,   700/822
(85 %)
10 diff
(98.8 %id)
CR456744   .a 358 to 1652 1 to 1295       1295/1299
(99 %)
1 diff
(100.0 %id)
CV026650 mixed .a 358 to 968 1 to 611       611/638
(95 %)
0 diff
(100 %id)
AW341586 pooled .a 364 to 867 1 to 504     Submitted on the opposite strand 504/504
(100 %)
4 diff
(99.3 %id)
AA521372 germinal center B cell .a 397 to 882 1 to 486     Submitted on the opposite strand 486/486
(100 %)
11 diff
(97.8 %id)
AA806168 germinal center B cell .a 397 to 846 1 to 451     Submitted on the opposite strand 451/451
(100 %)
5 diff
(98.9 %id)
AA626039   .a 417 to 463 1 to 52     Submitted on the opposite strand 52/52
(100 %)
3 diff
(94.3 %id)
BF980028 testis .a 419 to 1189 771 to 1   fully sequenced,   771/771
(100 %)
8 diff
(99.0 %id)
BM541279 leiomyosarcoma, uterus .a 508 to 1491 1 to 986       986/1089
(90 %)
18 diff
(98.4 %id)
BU164271 embryonal carcinoma, cell line, testis .a 528 to 1425 1 to 900       900/902
(99 %)
8 diff
(99.2 %id)
BG031957 breast, mammary adenocarcinoma, cell line .a 562 to 1280 1 to 713       713/929
(76 %)
11 diff
(98.9 %id)
BX103795 liver and spleen .a 571 to 1334 1 to 764       764/764
(100 %)
2 diff
(99.8 %id)
R94449 liver and spleen .a 582 to 867 1 to 286       286/286
(100 %)
3 diff
(99.0 %id)
BQ437959 leiomyosarcoma, uterus .a 761 to 1302 1 to 547       547/1067
(51 %)
15 diff
(98.6 %id)
BG254173 adenocarcinoma, cell line, Prostate .a 820 to 1561 1 to 740       738/897
(82 %)
11 diff
(98.8 %id)
CN309340 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 871 to 1485 1 to 616       616/616
(100 %)
3 diff
(99.6 %id)
BE962816 adenocarcinoma, ovary .a 886 to 1390 17 to 521     Submitted on the opposite strand 505/522
(96 %)
1 diff
(99.9 %id)
BE867884 adenocarcinoma, colon .a 909 to 1638 1 to 726       726/932
(77 %)
13 diff
(98.7 %id)
TI_1948093647   .a 935 to 1655 845 to 125   fully sequenced,   721/845
(85 %)
0 diff
(100 %id)
CR596381 Neuroblastoma Cot 25-normalized .a 969 to 2539 1 to 1571       1571/1571
(100 %)
0 diff
(100 %id)
AL526483 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 977 to 1859 8 to 890   fully sequenced,   883/890
(99 %)
6 diff
(99.4 %id)
TI_1948093806   .a 999 to 1655 780 to 124   fully sequenced,   657/780
(84 %)
0 diff
(100 %id)
TI_1948093976   .a 999 to 1655 782 to 126   fully sequenced,   657/782
(84 %)
0 diff
(100 %id)
TI_1948094144   .a 999 to 1655 783 to 127   fully sequenced,   657/783
(83 %)
0 diff
(100 %id)
CD244582 testis .a 1002 to 1793 32 to 828       797/916
(87 %)
11 diff
(98.8 %id)
BE315517 adenocarcinoma cell line, ovary .a 1030 to 1607 30 to 607       578/607
(95 %)
6 diff
(99.1 %id)
CN309342 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1037 to 1741 1 to 704       704/704
(100 %)
2 diff
(99.8 %id)
BE869112 adenocarcinoma, colon .a 1088 to 1561 1 to 487       487/799
(60 %)
35 diff
(95.7 %id)
BU857749 adenocarcinoma, cell line, breast .a 1095 to 1928 1 to 851       851/950
(89 %)
31 diff
(96.8 %id)
BF331428 breast .a 1115 to 1296 187 to 4       184/191
(96 %)
2 diff
(99.0 %id)
BP431947   .a 1120 to 1476 1 to 357       357/357
(100 %)
1 diff
(99.8 %id)
BE268193 Burkitt lymphoma, lymph .a 1138 to 1567 1 to 430       430/430
(100 %)
0 diff
(100 %id)
CB160809 Liver .a 1157 to 1660 1 to 504       504/504
(100 %)
6 diff
(98.9 %id)
CX755970 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 1170 to 1886 1 to 717     Submitted on the opposite strand 717/717
(100 %)
8 diff
(98.9 %id)
AA630784   .a 1176 to 1553 1 to 380     Submitted on the opposite strand 380/380
(100 %)
2 diff
(99.5 %id)
BG107614 Bone, osteosarcoma, cell line .a 1206 to 2008 1 to 808       808/829
(97 %)
20 diff
(97.6 %id)
BI090811 cervix .a 1223 to 1941 1 to 735       733/915
(80 %)
30 diff
(96.8 %id)
BF082659 breast .a 1250 to 1439 1 to 184       184/184
(100 %)
9 diff
(95.2 %id)
BG949505 breast .a 1250 to 1439 1 to 184       184/184
(100 %)
9 diff
(95.2 %id)
BG949556 breast .a 1250 to 1439 1 to 184       184/184
(100 %)
9 diff
(95.2 %id)
T74142 whole brain .a 1253 to 1641 1 to 398       398/413
(96 %)
14 diff
(96.7 %id)
BG108595 Bone, osteosarcoma, cell line .a 1255 to 2007 3 to 756       754/899
(83 %)
39 diff
(95.7 %id)
BU501414 eye, normal pigmented retinal epithelium .a 1263 to 2173 1 to 920       920/946
(97 %)
42 diff
(95.6 %id)
CR593914 Neuroblastoma Cot 25-normalized .a 1275 to 2485 1 to 1211       1211/1211
(100 %)
0 diff
(100 %id)
AL526849 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 1275 to 1739 1 to 454   fully sequenced,   454/454
(100 %)
0 diff
(100 %id)
AA292903   .a 1300 to 1727 1 to 427   fully sequenced,   427/427
(100 %)
2 diff
(99.6 %id)
BF154809 breast .a 1308 to 1425 1 to 118       118/118
(100 %)
4 diff
(96.7 %id)
CN309341 embryonic stem cells, cell lines H1, H7, andH9 .a 1315 to 1866 1 to 550       550/550
(100 %)
3 diff
(99.5 %id)
BG254664 adenocarcinoma, cell line, Prostate .a 1359 to 1997 1 to 642   AAA   642/642
(100 %)
8 diff
(98.8 %id)
DN601567 human embryonic stem cells .a 1367 to 2133 1 to 767       767/767
(100 %)
1 diff
(99.9 %id)
CA454911   .a 1378 to 2200 1 to 834       834/836
(99 %)
18 diff
(97.9 %id)
AI141851 heart .a 1410 to 1870 461 to 1       461/461
(100 %)
1 diff
(99.8 %id)
BM792756 stomach .a 1411 to 2100 1 to 690       690/690
(100 %)
1 diff
(99.9 %id)
BM836153 stomach .a 1411 to 1792 1 to 382       382/382
(100 %)
0 diff
(100 %id)
TI_59394059   .a 1435 to 2127 86 to 782       697/867
(80 %)
8 diff
(99.1 %id)
BM015790 breast, mammary adenocarcinoma, cell line .a 1436 to 2127 1 to 696       696/866
(80 %)
8 diff
(99.1 %id)
BF082660 breast .a 1456 to 1642 1 to 187       187/187
(100 %)
1 diff
(99.5 %id)
BG949506 breast .a 1456 to 1642 1 to 187       187/187
(100 %)
1 diff
(99.5 %id)
BG949557 breast .a 1456 to 1642 1 to 187       187/187
(100 %)
1 diff
(99.5 %id)
AI122551 heart .a 1460 to 1842 382 to 1       382/382
(100 %)
3 diff
(99.3 %id)
BF035176 adenocarcinoma, ovary .a 1466 to 2191 1 to 726       726/1042
(69 %)
24 diff
(97.7 %id)
BG392488 embryonal carcinoma, cell line, testis .a 1476 to 2087 1 to 611       611/611
(100 %)
2 diff
(99.7 %id)
AA114129   .a 1480 to 1923 1 to 450       450/451
(99 %)
6 diff
(98.7 %id)
BE695874 colon .a 1491 to 2032 539 to 2       538/539
(99 %)
0 diff
(100 %id)
BU596813 mixed (pool of 40 RNAs) .a 1515 to 2214 1 to 701       701/772
(90 %)
5 diff
(99.4 %id)
BG612970 embryonal carcinoma, testis .a 1517 to 2262 1 to 753       753/753
(100 %)
11 diff
(98.6 %id)
BU619589 Cell Line, Chondrosarcoma .a 1522 to 2263 759 to 19   AAA   741/741
(100 %)
1 diff
(99.9 %id)
AI183966   .a 1566 to 2097 533 to 2       532/533
(99 %)
0 diff
(100 %id)
CA431288 cell lines, Enchondroma .a 1568 to 2210 658 to 19   AAA   640/640
(100 %)
2 diff
(99.7 %id)
BQ775598 Bone, Human Chondrosarcoma Cell Line .a 1583 to 2210 637 to 17   AAA   621/621
(100 %)
8 diff
(98.8 %id)
AA461026   .a 1597 to 1924 1 to 327       327/327
(100 %)
1 diff
(99.7 %id)
AL522727 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 1602 to 2345 1 to 743       743/830
(89 %)
29 diff
(96.6 %id)
CA426431 cell lines, Chondrosarcoma .a 1605 to 2263 677 to 19   AAA   659/659
(100 %)
3 diff
(99.6 %id)
R94450 liver and spleen .a 1607 to 1995 392 to 1       392/392
(100 %)
4 diff
(99.0 %id)
BX334098 Neuroblastoma Cot 50-normalized .a 1621 to 2599 980 to 1       980/1037
(94 %)
41 diff
(96.1 %id)
TI_154057731   .a 1627 to 2459 921 to 97   AAA   825/913
(90 %)
19 diff
(98.0 %id)
TI_149313219   .a 1629 to 2464 933 to 105   AAA   829/979
(84 %)
19 diff
(98.1 %id)
BM564629 duodenal adenocarcinoma, cell line, small intestine .a 1648 to 2456 854 to 34   AAA Submitted on the opposite strand 821/1035
(79 %)
17 diff
(98.4 %id)
BF029279 bladder, carcinoma, cell line .a 1651 to 2168 1 to 515       515/803
(64 %)
14 diff
(98.3 %id)
AI183968   .a 1662 to 2096 450 to 16   AAA   435/435
(100 %)
3 diff
(99.4 %id)
AA668813 lung, lung carcinoma .a 1665 to 1779 1 to 115     Submitted on the opposite strand 115/115
(100 %)
1 diff
(99.2 %id)
BQ440449 leiomyosarcoma, uterus .a 1674 to 2553 1 to 893       893/898
(99 %)
23 diff
(97.5 %id)
BG166179 hypernephroma, cell line, Kidney .a 1692 to 2210 1 to 517   AAA   517/517
(100 %)
2 diff
(99.7 %id)
AA401737   .a 1697 to 1998 303 to 1   fully sequenced,   303/303
(100 %)
1 diff
(99.7 %id)
AL562757 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 1709 to 2485 777 to 1   fully sequenced,   777/777
(100 %)
6 diff
(99.3 %id)
BF332528 breast .a 1739 to 2079 25 to 365       341/365
(93 %)
6 diff
(98.4 %id)
CB119037 Liver .a 1739 to 2398 1 to 660       660/660
(100 %)
0 diff
(100 %id)
BE694490 breast .a 1742 to 2125 19 to 402       384/402
(95 %)
11 diff
(97.3 %id)
BE090548 breast .a 1752 to 2166 1 to 416       416/416
(100 %)
1 diff
(99.8 %id)
AA504581 germinal center B cell .a 1762 to 2223 10 to 471   fully sequenced,   462/471
(98 %)
6 diff
(98.8 %id)
AA134541 lung, lung carcinoma .a 1770 to 2286 1 to 515   fully sequenced,   515/515
(100 %)
0 diff
(100 %id)
BM458758 lymph, lymphoma, cell line .a 1785 to 2596 1 to 812   AAA   812/812
(100 %)
5 diff
(99.4 %id)
CA423562 cell lines, Chondrosarcoma .a 1807 to 2515 726 to 19   AAA   708/708
(100 %)
2 diff
(99.8 %id)
BI253342 cervical carcinoma cell line, cervix .a 1809 to 2596 1 to 788   AAA   788/788
(100 %)
9 diff
(98.9 %id)
CF541257 lung .a 1809 to 2464 673 to 19   AAA   655/655
(100 %)
1 diff
(99.9 %id)
BM999741 Fibrosarcoma .a 1814 to 2602 802 to 19   AAA   784/786
(99 %)
5 diff
(99.4 %id)
CA419343 Bone, Human Chondrosarcoma Cell Line .a 1814 to 2459 663 to 19   AAA   645/645
(100 %)
1 diff
(99.9 %id)
AL526443 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 1829 to 2539 708 to 1   fully sequenced,   708/708
(100 %)
7 diff
(99.1 %id)
BM790622 stomach .a 1836 to 2552 1 to 719       719/719
(100 %)
2 diff
(99.8 %id)
DR157574 human embryonic stem cells differentiated toan early endodermal cell type .a 1844 to 2596 767 to 15   AAA Submitted on the opposite strand 753/753
(100 %)
1 diff
(99.9 %id)
BM995100 Chondrosarcoma, Left Pubic Bone .a 1850 to 2454 623 to 19   AAA   605/605
(100 %)
0 diff
(100 %id)
AA251208 germinal center B cell .a 1854 to 2029 1 to 178       178/178
(100 %)
2 diff
(98.9 %id)
BF744501 breast .a 1855 to 2188 131 to 464       334/464
(71 %)
6 diff
(98.8 %id)
CX758509 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 1866 to 2616 776 to 37   AAA   740/740
(100 %)
22 diff
(97.1 %id)
BF220171 lung, small cell carcinoma .a 1885 to 2522 638 to 3       636/703
(90 %)
0 diff
(100 %id)
BU194685 melanotic melanoma, skin .a 1885 to 2602 756 to 38     Submitted on the opposite strand 719/939
(76 %)
0 diff
(100 %id)
AW967466   .a 1891 to 2595 703 to 1     Submitted on the opposite strand 703/705
(99 %)
7 diff
(99.1 %id)
TI_154060314   .a 1919 to 2596 759 to 82   AAA   678/986
(68 %)
7 diff
(99.3 %id)
CA419984 Bone, Human Chondrosarcoma Cell Line .a 1924 to 2596 689 to 17   AAA   673/677
(99 %)
4 diff
(99.5 %id)
BU619503 Cell Line, Chondrosarcoma .a 1924 to 2596 690 to 17   AAA   674/678
(99 %)
5 diff
(99.3 %id)
CA430053 cell lines, Chondrosarcoma .a 1929 to 2596 684 to 19   AAA   666/666
(100 %)
2 diff
(99.7 %id)
AI018417   .a 1991 to 2466 478 to 3       476/478
(99 %)
0 diff
(100 %id)
AI890569 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 1991 to 2601 613 to 3       611/613
(99 %)
0 diff
(100 %id)
AA114284   .a 2008 to 2213 207 to 1       207/209
(99 %)
1 diff
(99.6 %id)
BE694489 breast .a 2041 to 2412 374 to 3       372/374
(99 %)
0 diff
(100 %id)
AW245430 lung, small cell carcinoma .a 2053 to 2596 554 to 11   AAA   544/544
(100 %)
1 diff
(99.9 %id)
AA716100 heart .a 2059 to 2598 540 to 1       540/540
(100 %)
0 diff
(100 %id)
BE349100 malignant melanoma, metastatic to lymphnode, skin .a 2070 to 2601 533 to 1       533/533
(100 %)
2 diff
(99.7 %id)
AW007741 thymus, pooled .a 2081 to 2598 519 to 2       518/519
(99 %)
0 diff
(100 %id)
AI885478 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 2082 to 2598 517 to 1       517/517
(100 %)
0 diff
(100 %id)
AA035686 heart .a 2088 to 2295 1 to 208   fully sequenced,   208/208
(100 %)
0 diff
(100 %id)
AA456703 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2088 to 2220 1 to 132   fully sequenced,   132/132
(100 %)
1 diff
(99.3 %id)
DB512288 testis .a 2097 to 2515 1 to 420     Submitted on the opposite strand 420/420
(100 %)
23 diff
(94.6 %id)
AI590851 normal gingiva (cell line from immortalizedkeratinocytes) .a 2101 to 2602 502 to 1       502/502
(100 %)
1 diff
(99.9 %id)
AI126434   .a 2110 to 2598 491 to 3       489/491
(99 %)
0 diff
(100 %id)
AI745513 ovary, tumor, 5 pooled (see description) .a 2112 to 2596 485 to 1       485/485
(100 %)
0 diff
(100 %id)
AI572647 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 2121 to 2598 484 to 7       478/484
(98 %)
0 diff
(100 %id)
DB521598 testis .a 2123 to 2598 1 to 476     Submitted on the opposite strand 476/478
(99 %)
1 diff
(99.8 %id)
CR739834   .a 2134 to 2596 1 to 463   AAA   463/463
(100 %)
0 diff
(100 %id)
CR746023 liver and spleen .a 2134 to 2596 1 to 463   AAA   463/463
(100 %)
0 diff
(100 %id)
R84564 liver and spleen .a 2134 to 2406 1 to 276       276/276
(100 %)
3 diff
(99.0 %id)
W87693 liver and spleen .a 2134 to 2556 1 to 425       425/425
(100 %)
2 diff
(99.6 %id)
DB518969 testis .a 2138 to 2596 1 to 459     Submitted on the opposite strand 459/459
(100 %)
0 diff
(100 %id)
DB508955 testis .a 2149 to 2514 7 to 373     Submitted on the opposite strand 367/374
(98 %)
2 diff
(99.5 %id)
TI_159714534   .a 2160 to 2671 604 to 93   AAA   512/1013
(50 %)
1 diff
(100.0 %id)
CB307000 Human Lung Epithelial cells, lung .a 2160 to 2671 530 to 19   AAA   512/518
(98 %)
1 diff
(99.9 %id)
DB515640 testis .a 2166 to 2596 1 to 430     Submitted on the opposite strand 430/430
(100 %)
14 diff
(96.8 %id)
DB509569 testis .a 2171 to 2596 1 to 426     Submitted on the opposite strand 426/426
(100 %)
1 diff
(99.8 %id)
AI274246 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2175 to 2596 433 to 12   AAA   422/422
(100 %)
0 diff
(100 %id)
AA251127.
matches multiple genes
germinal center B cell .a 2176 to 2596 421 to 1     also hits gene PI4KB 421/421
(100 %)
0 diff
(100 %id)
DB521076 testis .a 2179 to 2604 1 to 426     Submitted on the opposite strand 426/428
(99 %)
2 diff
(99.6 %id)
AA456305 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2190 to 2596 417 to 11   fully sequenced, AAA   407/407
(100 %)
0 diff
(100 %id)
AA504500 germinal center B cell .a 2193 to 2603 413 to 3   fully sequenced,   411/413
(99 %)
5 diff
(98.8 %id)
AA524578 colon .a 2196 to 2596 397 to 1       397/397
(100 %)
6 diff
(98.5 %id)
AI473676 colon, moderately-differentiated adenocarcinoma .a 2207 to 2598 395 to 4       392/395
(99 %)
0 diff
(100 %id)
AI222896 carcinoid, lung .a 2213 to 2596 384 to 1       384/384
(100 %)
0 diff
(100 %id)
AI222899 carcinoid, lung .a 2213 to 2596 384 to 1       384/384
(100 %)
1 diff
(99.8 %id)
T16428   .a 2217 to 2596 380 to 1       380/380
(100 %)
2 diff
(99.5 %id)
R12705 liver and spleen .a 2235 to 2526 293 to 1       293/295
(99 %)
3 diff
(99.0 %id)
TI_149306601   .a 2243 to 2596 441 to 88   AAA   354/358
(98 %)
7 diff
(98.1 %id)
AA129647 lung, lung carcinoma .a 2256 to 2596 364 to 23   fully sequenced, AAA   342/342
(100 %)
0 diff
(100 %id)
AA005213 liver and spleen .a 2259 to 2554 297 to 1       297/297
(100 %)
1 diff
(99.7 %id)
AW591056 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 2261 to 2601 342 to 2       341/342
(99 %)
0 diff
(100 %id)
AA063557 heart .a 2265 to 2596 347 to 11   fully sequenced, AAA   337/337
(100 %)
2 diff
(99.5 %id)
CN309343 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2291 to 2593 303 to 1     Submitted on the opposite strand 303/303
(100 %)
0 diff
(100 %id)
F10153 brain, total brain .a 2306 to 2596 291 to 1       291/291
(100 %)
1 diff
(99.7 %id)
AI383949 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2369 to 2596 243 to 16   AAA   228/228
(100 %)
0 diff
(100 %id)
DB517140 testis .a 2390 to 2598 1 to 211     Submitted on the opposite strand 211/213
(99 %)
6 diff
(97.2 %id)
AA460677   .a 2448 to 2598 153 to 3       151/153
(98 %)
0 diff
(100 %id)
CX786775 human embryonic stem cells .a 2587 to 3323 9 to 745   tiling clone,   737/745
(98 %)
6 diff
(99.2 %id)
NM_001166260.1   .b 1 to 1482 1 to 1482 exact RefSeq,   1482/1482
(100 %)
0 diff
(100 %id)
AK310376 testis .b 31 to 1482 1 to 1452   tiling clone,   1452/1452
(100 %)
6 diff
(99.6 %id)
BF981362 duodenal adenocarcinoma, cell line, small intestine .c 1 to 746 13 to 765 D137R V138C E139G V140S K141Q ... tiling clone,   751/765
(98 %)
30 diff
(96.1 %id)
AA263081   .d 1 to 373 1 to 373 E86* tiling clone,   373/381
(97 %)
11 diff
(97.2 %id)
BM921888 pooled brain, lung, testis .e 1 to 926 11 to 948 exact tiling clone,   938/1023
(91 %)
22 diff
(97.9 %id)
AW160478 brain, frontal lobe .f 1 to 456 1 to 456 exact tiling clone,   456/456
(100 %)
0 diff
(100 %id)
AW161027 brain, frontal lobe .f 15 to 453 1 to 439 exact     439/439
(100 %)
0 diff
(100 %id)
AW161116 brain, frontal lobe .f 15 to 432 1 to 418 exact     418/418
(100 %)
0 diff
(100 %id)
AW161726 brain, frontal lobe .f 659 to 1236 586 to 9   tiling clone,   578/586
(98 %)
0 diff
(100 %id)
AW162098 brain, frontal lobe .f 715 to 1236 530 to 9       522/530
(98 %)
0 diff
(100 %id)
AW161707 brain, frontal lobe .f 854 to 1236 391 to 9       383/391
(97 %)
0 diff
(100 %id)
BF001872 colon, colon tumor, RER+ .g 1 to 571 571 to 1 K18X tiling clone,   571/571
(100 %)
0 diff
(100 %id)
DB516347 testis .g 107 to 559 1 to 453     Submitted on the opposite strand 453/453
(100 %)
0 diff
(100 %id)
AI382344   .h 1 to 306 315 to 10 exact tiling clone,   306/315
(97 %)
0 diff
(100 %id)
DW446834 Liver .i-u 1 to 195 7 to 200   tiling clone, AAA   194/209
(92 %)
6 diff
(97.2 %id)
DW457820 Liver .i-u 142 to 298 3 to 159   tiling clone,   157/159
(98 %)
6 diff
(96.3 %id)
BQ429981 testis .j 1 to 297 1 to 297 exact tiling clone, AAA   297/297
(100 %)
0 diff
(100 %id)
AA773785   Gene TRIP13, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
L40384   Gene TRIP13, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i-u, .j Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI